Did you know? The tiny C. elegans worm shares 60-80% of its genes with humans, making it an invaluable tool in genetic research. At Rafa’s Moonshot, we’re using these remarkable creatures, among other models, to pave the way for breakthrough treatments for STXBP1 disorders.
When it comes to finding a cure for rare genetic conditions like STXBP1, disease models are indispensable. But what exactly are they? In essence, disease models are systems—ranging from simple organisms like worms to complex human cells, rodents, and non-human primates—that replicate the key features of a disease. These models allow scientists to study the disease in detail, identify potential treatments, and predict how these treatments might work in humans.
Our Ongoing Disease Model Projects
The first thing we did after Raphael’s diagnosis was to start building our research infrastructure, with a primary focus on developing robust disease models. At Rafa’s Moonshot, we’re creating a range of innovative models specifically tailored to STXBP1 disorders:
- C. elegans (Worm) Model: We are using a C.elegans model that was developed by Invivo Bio. These worms carry the R292C mutation found in Raphael. This tiny worm, despite its simplicity, shares many genetic similarities with humans and exhibits altered movement patterns due to the mutation. This model is instrumental for rapidly screening potential drugs. So far, we’ve identified several compounds that show promise in restoring normal movement in these worms, offering early insights into potential therapeutic avenues.
- Induced Pluripotent Stem Cells (iPSCs): iPSCs are a cutting-edge tool in disease modeling. These cells are derived from a patient’s own skin or blood cells and reprogrammed to an embryonic-like state. At Rafa’s Moonshot, we’ve created iPSCs from Raphael’s cells, allowing us to generate neurons—specific brain cells that are directly affected by STXBP1 mutations. By studying these neurons in the lab, we can observe how the STXBP1 mutation alters cellular behavior and test the effectiveness of different drugs in a system that closely mimics Raphael’s own brain. This personalized approach is a powerful way to understand the disease at a cellular level and tailor potential treatments specifically to Raphael’s needs.
- Mouse Model: We’re developing a mouse model with Raphael’s specific mutation in the Czech Republic. This model is crucial for understanding the mutation’s impact on a whole-organism level, including complex brain functions. By studying this mouse model, we aim to explore how the mutation affects neurological development and behavior, providing a critical bridge between basic research and potential clinical applications.
Exploring Other Potential Disease Models
In addition to these ongoing projects, we’re exploring other disease models that could offer even deeper insights into STXBP1 disorders:
- Zebrafish Models: Zebrafish are another powerful model organism, especially for studying neurological diseases. They are transparent during early development, which allows for real-time observation of how STXBP1 mutations affect brain function and behavior. Their rapid reproduction and development make them ideal for high-throughput drug screening.
- Drosophila (Fruit Fly) Models: The fruit fly is a classic model organism in genetics. Despite its simplicity, Drosophila shares many genetic similarities with humans, and researchers can manipulate its genes to study the effects of STXBP1 mutations. The fly’s nervous system, though simpler, can provide valuable insights into the fundamental mechanisms of the disorder.
- Organoids: Organoids are miniature, simplified versions of organs created in the lab from stem cells. These three-dimensional structures mimic the organization and function of real human organs, such as the brain. In the context of STXBP1 research, brain organoids can be developed from iPSCs and used to study the development and progression of the disease in a more complex, yet still controlled environment. This approach allows us to observe how STXBP1 mutations impact the brain and its function over time and test potential treatments in a setting that closely mimics the human brain.
Why These Models Matter
These disease models are not just scientific tools—they are our best hope for understanding STXBP1 disorders and developing effective treatments. By studying how the disease unfolds in these models, we can explore new therapies that could one day lead to a cure. Every step forward with these models brings us closer to changing the lives of those affected by STXBP1.
Stay tuned as we continue to share our progress and breakthroughs on this exciting journey.
